NewGenIvf
NIVF
1 hedge funds and large institutions have $578 invested in NewGenIvf in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
95% less capital invested
Capital invested by funds: $10.8K → $578 (-$10.2K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SS
SBI Securities
Tokyo,
Japan
|
+$840 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MG
Marex Group
London,
|
-$10.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$363 |
NIVF Hedge Fund Activity: Q3 2025 in Review
1 of the 7,638 institutional investors tracked by Wall St. Rank reported a position in NewGenIvf (NIVF) for Q3 2025, worth a combined $578 — down 95% from $10.8K a quarter earlier.
Fund positioning in NIVF was balanced in Q3 2025: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was SBI Securities, opening a new position worth an estimated $840. The largest seller was Marex Group, exiting entirely with an estimated $10.4K sold.
- 1 institutional investor held NewGenIvf (NIVF) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $578 of NewGenIvf stock for Q3 2025, down 95% quarter-over-quarter.
- 1 fund opened new NewGenIvf positions in Q3 2025 and 1 closed out, a net change of 0 holders.
- The largest NewGenIvf buyer in Q3 2025 was SBI Securities, an estimated $840 added.
- The largest NewGenIvf seller in Q3 2025 was Marex Group, an estimated $10.4K sold.
Based on aggregated 13F filings for Q3 2025.